Polymyalgia rheumatica (PMR) is a relatively common cause of widespread aching and stiffness in older adults. PMR can overlap with another rheumatic disease called giant cell arteritis, and symptoms of the two conditions can occur at the same time or separately. (See p. 12 of the March 2008 issue for more on giant cell arteritis.) The typical symptoms of PMR include aching and stiffness around the upper arms, neck, lower back, buttocks, and thighs. Symptoms tend to develop quickly over a period of several days or weeks, and occasionally even overnight.
Audioconference Offers Advice on Pain Associated with Juvenile Arthritis
What is the pain puzzle? “It is a bio-psycho social model of pain that is accepted in the field of rheumatology,” according to Michael Rapoff, PhD, professor of pediatrics at the University of Kansas Medical Center in Kansas City and the highlighted speaker for the ARHP audioconference on April 17.
Avoid Compliance Risks When Using Billing Companies
Outsourcing your billing to a third party will not alleviate your compliance duties or reduce your risk of a government investigation. Conversely, a relationship with a third-party biller can increase your compliance obligations and raise audit risks.
A New Twist in the Consumerization of Healthcare
Who are the new medical consumers? These people behave like medical “shoppers” because they are more mobile than previous generations and are empowered by the Internet. They can research and form opinions about diseases, treatment options, and the best route to recovery—all before stepping foot in to an exam room. This emerging population has been taught that in order to be a health-wise consumer and to get the most value, a patient must take an active role in his or her care.
Giant Cell Arteritis
Giant cell arteritis (GCA)—a type of vasculitis—is a group of diseases whose typical feature is inflammation of blood vessels. The blood vessels most commonly involved are the arteries of the scalp and head (especially the arteries over the temples), which is why another term for GCA is “temporal arteritis.” GCA can overlap with another rheumatic disease called polymyalgia rheumatica, and symptoms of the two conditions can occur at the same time or separately. The causes of GCA and polymyalgia rheumatica are unknown.
Eye on the Election
Over the past two years, we have heard presidential candidates touting their messages to voters. Each candidate has crafted messages they believe will appeal to voters, and as campaigns continue to accelerate, these messages will saturate the radio, television, and the reading materials of the American public.
Bring a New Partner Into Your Rheumatology Practice
The professional relationship between partners in a joint medical practice is sometimes compared with a marriage. The partners must work under the same roof, share the same goals, and strive to make the practice as successful as it can be. Here are some tips for adding a new partner to your practice.
Research Funded by Within Our Reach Highlighted
Five Within Our Reach science investigators provided overviews and updates of their RA research projects to the newly formed Within Our Reach advisory board at its inaugural meeting, held November 8, 2007.
Meet the Affiliate Society Council
The Affiliate Society Council (ASC), a subcommittee of the Committee on Rheumatologic Care, will replace the Regional Advisory Council as a support mechanism for the ACR when working with rheumatology programs at the local and national level. It launched in January. The ASC and the ACR will work in conjunction with state and local societies on practice advocacy issues and create best practices for information sharing.
ACR Master Wins 2007 Leadership in Personalized Medicine Award
ACR Master Ralph Snyderman, MD, chancellor emeritus for health affairs at Duke University in Durham, N.C., and founder and chairman of Proventys Inc., recently received the 2007 Leadership in Personalized Medicine Award. The award, given by the Personalized Medicine Coalition (PMC), honors Dr. Snyderman’s efforts to advance predictive and targeted therapies on a national scale.
- « Previous Page
- 1
- …
- 117
- 118
- 119
- 120
- 121
- …
- 133
- Next Page »